bal 1

Mal-GGG-Bal-NHS 酯是ADC接枝体，用于合成抗体药物偶联物(ADC)。

Lisavanbulin (BAL-101553)，作为微管蛋白靶向剂Avanbulin（BAL 27862）的前体药物，显示出对高水平表达末端结合蛋白 1 的肿瘤具有显著的抗肿瘤活性。

AM679 is a potent and selective FLAP inhibitor with IC50s of 2.2 nM 0.6 nM 154 nM for FLAP binding hLA hWB respectively. IC50 value: 2.2 nM 0.6 nM 154 nM(FLAP binding hLA hWB) [1] AM679 showed an improved CYP inhibition profile (IC50 3A4 = 16.7 lM, 2C9 =

Lisavanbulin (BAL-101553) dihydrochloride 为微管蛋白靶向剂 Avanbulin (BAL 27862) 的前体化合物.该化合物表现出抗肿瘤活性,特别是对于高表达末端结合蛋白 1 的肿瘤细胞具有显著效果.

BAL30072 shows MIC90 values of 4 μg mL for MDR Acinetobacter spp. and 8 μg mL for MDR P. aeruginosa, respectively[1][2]. BAL-30072, a siderophore sulfactam, is a monocyclic beta-lactam antibiotic, with activity against multiresistant gram-negative bacilli